OGEN vs SO · rev $37.7K vs P/E 22, rev $6.26B
Oragenics Inc (OGEN) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
OGEN currently screens at market cap $2.7M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the OGEN and SO stock pages for the full models.
Not investment advice.